Drug maker Hexi Pharma on Friday was indicted by the General Prosecution Office for hindering disease combat in a case of diluted disinfectants in hospitals.
“In continuation of their probe in the case generally known as ‘Disinfectants used in hospitals,’ prosecutors of the Criminal Investigation and Forensic Department of the Prosecution Office with the Supreme Court of Justice, have ordered the probe of Hexi Pharma CO SRL to continue for the offence of being a hindrance to disease combat, provided for and penalised under Article 52 (3) corroborated with Article 352 (1) in the Criminal Code, in application of Article 35(1) in the Criminal Code,” the General Prosecution Office reported in a press statement on Friday.
It says that the legal representative of the company was informed on Friday that Hexi Pharma Co SRL was indicted.
Last week, prosecutors opened a criminal case based on public information on disinfectants produced by Hexi Pharma. A criminal investigation was initiated for the offences of hindering disease combat and falsification or substitution of food or other products.
Last Saturday, the investigators conduced searches at the Hexi Pharma headquarters and outlets, as well as at 25 medical units in 21 counties and Bucharest, where they seized samples and documents. On the same day, prosecutors conducted searches at Dan Condrea’s home.
Hexi Pharma alleges 20 million euros in debt to two Cyprus companies
In its application for insolvency filed with the Bucharest Tribunal, drug maker Hexi Pharma claims that it has 23.4 million lei in outstanding tax arrears and unpaid bills to suppliers, while also being more than 20 million euros in debt to two companies registered in Cyprus.
The two companies allegedly are Hatom Limited Limassol and Chemical&Pharmaceutical Sol LTD Nicosia, which Rise Project investigative journalists claim are two off-shore companies controlled by the owner of Hexi Pharma, Dan Condrea.
“Our company can no longer cope with commercial and tax liabilities triggered by unfavorable economic developments,” reads the application.
Enclosed with the application for insolvency was a book of receipts and payments covering October 1, 2015 – May 4, 2016 indicating 6,994 operations, receipts and payments. Total receipts are shown to be 16,506,657 lei and payments 16,619,607 lei.
Condrea also asked the court to appoint a receiver for his company from the Transilvania Insolvency House.
The application for insolvency was filed on May 10, with the first hearing of the trial set for May 17. It mentions bankruptcy for reasons regarding debtor’s request for receivership, as mentioned in Article 66 of Law 85/2014 on insolvency.
Computer searches in Hexi Pharma case
Officers of the Romanian Police General Inspectorate (IGPR) on Friday are conducting computer searches in the Hexi Pharma case, judicial sources tell Agerpres.
According to them, the Hexi Pharma general manager and the company’s chemical engineer would participate in the hearings.
Employees of the Hexi Pharma pharmaceutical company investigated in this case that entailed the provision of non-compliant hospital disinfectants were interviewed at the IGPR headquarters on Thursday.